Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 2
2010 3
2011 6
2012 5
2013 3
2014 8
2015 6
2016 6
2017 6
2018 2
2019 2
2020 5
2021 11
2022 8
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM, Ford D; ODYSSEY trial team. Turkova A, et al. Lancet Child Adolesc Health. 2023 Oct;7(10):718-727. doi: 10.1016/S2352-4642(23)00164-5. Epub 2023 Aug 8. Lancet Child Adolesc Health. 2023. PMID: 37562418 Free article. Clinical Trial.
The met and unmet health needs for HIV, hypertension, and diabetes in rural KwaZulu-Natal, South Africa: analysis of a cross-sectional multimorbidity survey.
Singh U, Olivier S, Cuadros D, Castle A, Moosa Y, Zulu T, Edwards JA, Kim HY, Gunda R, Koole O, Surujdeen A, Gareta D, Munatsi D, Modise TH, Dreyer J, Nxumalo S, Smit TK, Ordering-Jespersen G, Mpofana IB, Khan K, Sikhosana ZEL, Moodley S, Shen YJ, Khoza T, Mhlongo N, Bucibo S, Nyamande K, Baisley KJ, Grant AD, Herbst K, Seeley J, Pillay D, Hanekom W, Ndung'u T, Siedner MJ, Tanser F, Wong EB; Vukuzazi team. Singh U, et al. Among authors: koole o. Lancet Glob Health. 2023 Sep;11(9):e1372-e1382. doi: 10.1016/S2214-109X(23)00239-5. Lancet Glob Health. 2023. PMID: 37591585 Free PMC article.
Melioidosis, phnom penh, Cambodia.
Vlieghe E, Kruy L, De Smet B, Kham C, Veng CH, Phe T, Koole O, Thai S, Lynen L, Jacobs J. Vlieghe E, et al. Among authors: koole o. Emerg Infect Dis. 2011 Jul;17(7):1289-92. doi: 10.3201/eid1707.101069. Emerg Infect Dis. 2011. PMID: 21762590 Free PMC article.
Universal access to HIV care: pitfalls and the way forward.
De Ryck I, Koole O, Wanyenze R, Colebunders R. De Ryck I, et al. Among authors: koole o. Trop Med Int Health. 2008 Oct;13(10):1222-4. doi: 10.1111/j.1365-3156.2008.02135.x. Epub 2008 Aug 24. Trop Med Int Health. 2008. PMID: 18764816 Free article. No abstract available.
Cohort Profile: The Vukuzazi ('Wake Up and Know Yourself' in isiZulu) population science programme.
Gunda R, Koole O, Gareta D, Olivier S, Surujdeen A, Smit T, Modise T, Dreyer J, Ording-Jespersen G, Munatsi D, Nxumalo S, Khoza T, Mhlongo N, Baisley K, Seeley J, Grant AD, Herbst K, Ndung'u T, Hanekom WA, Siedner MJ, Pillay D, Wong EB; Vukuzazi Study Team. Gunda R, et al. Among authors: koole o. Int J Epidemiol. 2022 Jun 13;51(3):e131-e142. doi: 10.1093/ije/dyab229. Int J Epidemiol. 2022. PMID: 34849923 Free PMC article. No abstract available.
Pitfalls of Single Measurement Screening for Diabetes and Hypertension in Community-Based Settings.
Olivier S, Murray T, Matthews P, Mhlongo N, Gunda R, Baisley K, Gareta D, Modise T, Smit T, Herbst K, Mpofana X, Ndung'u T, Koole O, Pillay D, Hanekom W, Wong E, Siedner MJ; Vukuzazi Study team. Olivier S, et al. Among authors: koole o. Glob Heart. 2021 Dec 3;16(1):79. doi: 10.5334/gh.1083. eCollection 2021. Glob Heart. 2021. PMID: 34900570 Free PMC article.
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
Turkova A, White E, Mujuru HA, Kekitiinwa AR, Kityo CM, Violari A, Lugemwa A, Cressey TR, Musoke P, Variava E, Cotton MF, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch SB, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe GM, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb DM; ODYSSEY Trial Team. Turkova A, et al. N Engl J Med. 2021 Dec 30;385(27):2531-2543. doi: 10.1056/NEJMoa2108793. N Engl J Med. 2021. PMID: 34965338 Free PMC article. Clinical Trial.
76 results